Skip to main content
. 2022 Mar 21;45(4):319–331. doi: 10.1007/s40264-022-01151-w

Fig. 5.

Fig. 5

Percentages of participants who reported at least one of the following well-known systemic adverse events following immunization (AEFIs) stratified by a history of COVID-19 prior to vaccination: arthralgia, myalgia, nausea, pyrexia, headache, malaise, chills, fatigue, and fever (body temperature 38 °C or higher)